Page last updated: 2024-11-01

nialamide and Vertigo

nialamide has been researched along with Vertigo in 3 studies

Nialamide: An MAO inhibitor that is used as an antidepressive agent.

Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MEO, G1
CENZI, P1
Reisner, H1

Other Studies

3 other studies available for nialamide and Vertigo

ArticleYear
[TREATMENT OF OTOTOXIC MANIFESTATIONS DUE TO ANTITUBERCULAR ANTIBIOTIC THERAPY. CLINICAL USE OF A MONOAMINE OXIDASE INHIBITOR (NIALAMIDE)].
    Gazzetta internazionale di medicina e chirurgia, 1964, Apr-15, Volume: 68

    Topics: Antibiotics, Antitubercular; Antitubercular Agents; Audiometry; Cochlear Nerve; Deafness; Dihydrostr

1964
[CLINICAL TEST OF NIAMID IN OTORHINOLARYNGOLOGY].
    Lyon medical, 1964, Nov-01, Volume: 212

    Topics: Biomedical Research; Geriatrics; Neoplasms; Nialamide; Otolaryngology; Pain; Tinnitus; Toxicology; V

1964
[Conservative treatment of late stages of craniocerebral injuries].
    Wiener medizinische Wochenschrift (1946), 1968, Sep-21, Volume: 118, Issue:38

    Topics: Brain Injuries; Headache; Humans; Nialamide; Skull Fractures; Time Factors; Tranquilizing Agents; Ve

1968